Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yu R Yakshibaeva"'
Publikováno v:
Experimental Oncology.
Background Tumor drug resistance remains a primary cause of unsuccessful cancer therapy. The search for biological markers of the sensitivity/resistance of malignant neoplasms to drug therapy is an urgent and important task, the solution of which wil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7f71d8ddf6a3a73d0d49fe0506b456c
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15938
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15938
Publikováno v:
Experimental Oncology.
BACKGROUND Inhibition of aerobic glycolysis of cancer cells is considered a promising therapeutic strategy for the treatment of neoplasms. Some inhibitors of energy metabolism can affect not only tumor cells but also the functional polarization of tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::016bb0e811b813f23767b640d17608ef
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16530
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16530
Publikováno v:
Experimental oncology. 41(1)
The use of inhibitors of energy metabolism of malignant cells is a new promising trend in the treatment of cancer patients, based on one of the unique features of the malignant cell, namely the dominance of glycolysis over oxidative phosphorylation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80258fb6ace97f019816771379fad604
https://pubmed.ncbi.nlm.nih.gov/30932416
https://pubmed.ncbi.nlm.nih.gov/30932416
Publikováno v:
Experimental Oncology. 41
The use of inhibitors of energy metabolism of malignant cells is a new promising trend in the treatment of cancer patients, based on one of the unique features of the malignant cell, namely the dominance of glycolysis over oxidative phosphorylation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e3d8cb2504570fcfd045e177661a456
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12432
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12432
Publikováno v:
Reports of the National Academy of Sciences of Ukraine. :167-172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b51354737df7270af6698ccece16130
https://doi.org/10.15407/dopovidi2014.06.167
https://doi.org/10.15407/dopovidi2014.06.167
Publikováno v:
Bulletin of Experimental Biology & Medicine; Sep2004, Vol. 138 Issue 3, p295-297, 3p